The prevalence of hepatitis b antigen-positivity in the general population of Mashhad, Iran

Hepatitis Monthly

Volumn 11, Issue 5, 2011, Pages 346-350

  Fathimoghaddam, Farhad ^a   Hedayati Moghaddam, Mohammad Reza ^a   Bid Khori, Hamid Reza ^a   Ahmadi, Sanaz ^a   Sima, Hamid Reza ^a,b  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hbsag hepatitis b virus population group iran risk factor

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH SURVEY; HEPATITIS B; HIGH RISK POPULATION; HUMAN; INFANT; IRAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; SCHOOL CHILD;

EID: 79957666045     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Maynard JE. Hepatitis B: global importance and need for control. Vaccine. 1990;8(Suppl):S18-S20; discussion S1-S3.
2. McMahon BJ. Natural history of chronic hepatitis B - clinical implications. Medscape J Med. 2008;10(4):91.
3. Alter MJ, Hadler SC, Margolis HS, Alexander WJ, Hu PY, Jud-son FN, et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA. 1990;263(9):1218-1222.
4. WHO. Hepatitis B. [updated 2010]; Available from: http://www. who.int/csr/disease/hepatitis/HepatitisB_whocdscsrlyo2002_2. pdf.
5. Amini Kaf-abad S, Rezvan H, Abolghasemi H. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007. Transfus Med. 2009;19(4):189-194.
6. Shamszad M, Farzadegan H. [Hepatitis B related cirrhosis and hepatocellular carcinoma in Iran]. J Iran Med Council. 1982;8:228.
7. Zali MR, Mohammad K, Farhadi A, Masjedi MR, Zargar A, Now-roozi A. Epidemiology of hepatitis B in the Islamic Republic of Iran. East Mediterr Health J. 1996;2(2):290-298.
8. Farzadegan H, Harbour C, Ala F. The prevalence of hepatitis B surface antigen and its antibody in blood donors and high risk groups in Iran. Vox sanguinis. 1979;37(3):182-186.
9. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Lankarani KB. Hepatitis B Virus infection in Iran: A systematic review. Hepat Mon. 2008;8(4):281-94.
10. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iranian Med. 2000;3(4):192-201.
11. Zali MR, Mohammad K, Noorbala AA, Noorimayer B, Sahraz S. Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. East Mediterr Health J. 2005;11(1/2):62-67.
12. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007;16(4):403-406.
13. Beasley RP, Hwang LY, Lin CC, Leu ML, Stevens CE, Szmuness W, et al. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis. 1982;146(2):198-204.
14. Kim WR, Ishitani MB, Dickson ER. Rising burden of hepatitis B in the United States: should the other virus be forgotten. Hepatology. 2002;36(4):222A.
15. Farhat A, Khademi G, Mazlouman SJ. The prevalence of hepatitis B carrier state in Khorassan province of Iran. Saudi Med J. 2003;24(5):549-551.
16. Ghanaat J, Sadeghian A, Ghazvini K, Nassiri MR. Prevalence and risk factors for hepatitis B virus infections among STD patients in northeast region of Iran. Med Sci Monit. 2003;9(2):CR91-CR94.
17. Vossoughinia H, Shakeri TM, Mokhtari Amirmajdi E, Ravan bakhsh F, Abedini S. [Risk Factors for Hepatitis B and C in 400 Blood Donor Volunteers in Mashhad During 2003-2007: A Case-control Study]. Ofogh-e-Danesh J. 2010;15(4):68-75.
18. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine. 2000;18(Suppl 1):S20-S22.
19. Abdolahi N, Keshtkar AA, Semnani S, Roushandel GR, Besharat S, Joshaghani HR, et al. [HBV Seroprevalence among Golestan adults]. Iran J Epidemiol 2006;1(4):35-40.
20. Alizadeh AH, Ranjbar M, Ansari S, Alavian SM, Shalmani HM, Hekmat L, et al. Intra-familial prevalence of hepatitis B virologic markers in HBsAg positive family members in Nahavand, Iran. World J Gastroenterol. 2005;11(31):4857-4860.
21. Pourshams A, Malekzadeh R, Nasiri J. Prevalence, risk factors and intrafamilial spreading of hepatitis B virus in gonbad, iran. J Gastroenterol Hepatol. 2006;21(Suppl 2):A100.
22. Nokhodian Z, Kassaian N, Ataei B, Javadi A, Shoaei P, Farajzade-gan Z, et al. Hepatitis B Markers in Isfahan, Central Iran: A Population-Based Study. Hepat Mon. 2009;9(1):12-6.
23. Bayat-Makou J, Shahnazi A, Koushavar H. Prevalent infections in north-west region of Tabriz. Med J Tabriz Univ of Med Scie. 2003;25(3 suppl):30-40.
24. WHO. Iran (Islamic Republic of): WHO and UNICEF estimates of immunization coverage, 1997-2009. [updated 2010]; Available from: http://www.who.int/immunization_monitoring/data/irn. pdf.
25. Immunization programme and guideline. 5th ed. IR Iran: Ministry of Health and Medical Education Publishing; 1998.
26. Hajiani E, Hashemi S, Masjedizadeh A. Seroepidemiology of hepatitis B virus Infection in Khuzestan province, southwest of Iran. Hepat Mon. 2009;9(1):34-38.
27. Alavian SM, Gooya MM, Hajarizadeh B, Esteghamati AR, Moeinza-deh AM, Haghazali M, et al. Mass vaccination campaign against hepatitis B in adolescents in Iran: estimating coverage using administrative data. Hepat Mon. 2009;9(3):189-195.
28. Statistical Centre of Iran. Mean age at first marriage by sex. [updated 2010]; Available from: http://amar.sci.org.ir/Detail. aspx?Ln=E&no=98512&S=GW.
29. Adibi P, Rezailashkajani M, Roshandel D, Behrouz N, Ansari S, Somi MH, et al. An economic analysis of premarriage prevention of hepatitis B transmission in Iran. BMC Infect Dis. 2004;4:31.
30. Quddus A, Luby SP, Jamal Z, Jafar T. Prevalence of hepatitis B among Afghan refugees living in Balochistan, Pakistan. Int J Infect Dis. 2006;10(3):242-247.